RT @uptoTate: RELIANCE interim data shows that long-term CAN is safe & effective in CAPS. Interestingly, investigato

Social Author Image

https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3.jpg

Tweet Author

Social Author Name

Dr. Rachel Tate

Tweet Content

RELIANCE interim data shows that long-term CAN is safe & effective in CAPS. Interestingly, investigators observed a trend toward updosing over standard dosing. Abs 0191 #ACR21 #RheumNow @RheumNow https://t.co/ik6dAEZjFf https://t.co/arqSEzuC6Q

Links

Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients wi… http://ow.ly/rEpy50Gqh3d

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @uptoTate: RELIANCE interim data shows that long-term CAN is safe & effective in CAPS. Interestingly, investigato

Do you get our email newsletter?

RT @uptoTate: RELIANCE interim data shows that long-term CAN is safe &amp; effective in CAPS. Interestingly, investigato

RT @uptoTate: RELIANCE interim data shows that long-term CAN is safe & effective in CAPS. Interestingly, investigato